Dutch clinical virologist Joep Lange - who was among 298 passengers who died in the downing of Malaysia Airlines flight MH17 - worked since the early 1990s to deliver HIV drugs deep into the world's poorest countries.
He was one of the six scientists headed to attend the six-day 20th International AIDS Conference in Melbourne that started Sunday.
Lange's death has shocked the international public health and medical research communities, the scientific journal Nature reported.
"His contribution to HIV research and treatment and his determination to ensure access of those treatments for people in Africa and Asia, cannot be underestimated," said David Cooper, an AIDS researcher at University of New South Wales in Sydney.
Lange was a clinical virologist at University of Amsterdam.
His research explored HIV drug resistance, the role of anti-retroviral drugs in preventing transmission of virus from mother to child and other issues related to managing HIV AIDS.
His work helped to establish the safety and effectiveness of treating patients with multiple antiviral drugs, which is now standard.
In 2000, Lange helped launch the non-profit PharmAccess Foundation to bring anti-retroviral drugs to sub-Saharan Africa, where the HIV epidemic was in full swing and most patients remained untreated.
The foundation has since broadened its reach, creating a fund that subsidises health insurance for about 1,00,000 people in Nigeria, Tanzania and Kenya.
"This is a massive loss. We are devastated. Joep's dedication to the treatment of HIV AIDS and global health in general has been ground breaking," said Onno Schellekens, managing director of PharmAccess.
"He was very selfless. He believed we have made great scientific progress and people have to benefit from it," Robin Weiss, a virologist at University College London, emphasised.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
